Hydroxychloroquine retinopathy

Archives of Ophthalmology

Volumn 117, Issue 9, 1999, Pages 1262-1263

  Maturi, Raj K ^b   Folk, James C ^a   Nichols, Brian ^b   Oetting, Thomas T ^b   Kardon, Randy H ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE;

ADULT; ARTICLE; CASE REPORT; CENTRAL SCOTOMA; CRITICAL FLICKER FUSION; DRUG INDUCED DISEASE; ELECTRORETINOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; PRIORITY JOURNAL; RETINOPATHY; RHEUMATOID ARTHRITIS; VISUAL ACUITY;

EID: 0032871079     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.117.9.1262     Document Type: Article

References (4)

1. Levy GD, Munz SJ, Paschal J, Cohen HB, Pince KJ, Peterson T. Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice. Arthritis Rheum. 1997; 40:1482-1486.
2. Morsman CDG, Livesey SJ, Richards IM, Jessop JD, Mills PV. Screening for hydroxychloroquine retinal toxicity: is it necessary? Eye. 1990;4:572-576.
3. Mills PV, Beck M, Power BJ. Assessment of the retinal toxicity of hydroxychloroquine. Trans Ophthalmol Soc U K. 1981;101:109-113.
4. Bernstein HN. Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy. Am J Med. 1983;5(suppl): 25-34.